Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
Open-Angle Glaucoma, Ocular Hypertension

About this trial
This is an interventional treatment trial for Open-Angle Glaucoma focused on measuring Open-Angle Glaucoma (OAG), Ocular Hypertension (OHT), Bimatoprost
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of either Diagnosis of either open angle glaucoma (OAG) (i.e., primary OAG, pseudoexfoliation glaucoma, pigmentary glaucoma) or ocular hypertension requiring intraocular pressure-lowering treatment.
Exclusion Criteria:
- Concurrent or anticipated enrollment in another investigational drug or device study or participation in such a study within 2 months prior to enrolling in this study.
 - Previous administration with Bimatoprost SR in the study eye.
 
Sites / Locations
- Horizon Eye Specialists & Lasik Centers /ID# 235240
 - Atlantis Eye Care /ID# 235530
 - Lakeside Vision Center /ID# 234970
 - Global Research Foundation /ID# 237350
 - The Eye Research Foundation /ID# 234521
 - Byers Eye Institute Stanford /ID# 235544
 - Foothill Eye Institute /ID# 235640
 - Connecticut Eye Consultants P.C. /ID# 234981
 - Specialty Retina Center /ID# 236045
 - Segal Drug Trials, Inc /ID# 235784
 - International Research Center /ID# 238050
 - Thomas Eye Group PC /ID# 235737
 - Indiana University - Glick Eye Institute /ID# 235886
 - Midwest Eye Institute /ID# 237876
 - Tulane University /ID# 237632
 - Ophthalmic Consultants of Boston /ID# 236534
 - Clinical Eye Research of Boston LLC /ID# 234966
 - University of Michigan, Kellogg Eye Center /ID# 236496
 - Fraser Eye Center /ID# 235790
 - Silverstein Eye Centers /ID# 237881
 - Moyes Eye Center PC /ID# 234989
 - Alterman Modi & Wolter /ID# 235248
 - The Ohio State University /ID# 236790
 - AMA Eyes Research Institute /ID# 235542
 - Dean McGee Eye Institute /ID# 236823
 - Oklahoma Eye Surgeons /ID# 235849
 - Drs Fine Hoffman & Sims LLC /ID# 235918
 - Ophthalmic Partners, PC /ID# 235741
 - Scott and Christie and Associates /ID# 234593
 - Black Hills Regional Eye Institute /ID# 235075
 - Vance Thompson Vision /ID# 235072
 - Eye Specialty Group /ID# 235721
 - Vanderbilt University Medical Center /ID# 237177
 - Advancing Vision Research /ID# 236681
 - ATX Clinical Trials Inc. dba Keystone Research /ID# 235868
 - Medical Center Ophthalmology Associates - Keystone Research /ID# 235787
 - Southern Utah Medical Research /ID# 235602
 - Piedmont Eye Center /ID# 234534
 - Consultorio Oftalmologico Dr. Fabian Lerner /ID# 235855
 - Hospital Universitario Austral /ID# 237727
 - Oftalmología Global /ID# 239187
 - Hospital Italiano /ID# 235851
 - Centro Privado de Ojos /ID# 241283
 - Centro oftalmologico Dr Charles /ID# 235881
 - Oftar Mendoza /ID# 240535
 - Eye Surgery Associates /ID# 235873
 - Multiprofile Hospital for Active Treatment "Lozenetz" /ID# 244053
 - Medical Center Oxycom Burgas /ID# 235580
 - UMHAT Sveti Georgi /ID# 237027
 - MHAT Hadzhi Dimitar /ID# 238248
 - MHAT Dr. Bratan Shukerov /ID# 235498
 - Medical center for eye healt Focus Ltd /ID# 235575
 - Pentagram Eye Hospital /Id# 235813
 - Specialized Hospital for Active Treatment in Ocular Diseases "Zrenie" /ID# 235500
 - Diagnostic consultative center Aleksandrovska /ID# 238105
 - St. Sofia Hospital /ID# 235525
 - Medical Center -Verea /ID# 235494
 - Medical center Orfey /ID# 237344
 - MHAT Trakia /ID# 238137
 - Specialized Ophthalmological Hospital for Active Treatment - Varna /ID# 235962
 - Ocni klinika Pardubice /ID# 235944
 - Fakultni nemocnice Kralovske Vinohrady /ID# 234323
 - Vseobecna fakultni nemocnice v Praze /ID# 234422
 - Rigshospitalet Glostrup /ID# 235743
 - Universitatsklinikum Freiburg /ID# 238048
 - Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 237069
 - Klinikum Dresden Friedrichstadt /ID# 235308
 - Universitaetsmedizin Goettingen /ID# 237377
 - Asklepios Kinik Nord - Heidberg Augenklinik /ID# 235955
 - St. Franziskus-Hospital /ID# 237714
 - Dietrich-Bonhoeffer-Klinikum /ID# 235262
 - Universitaetsmedizin Rostock /ID# 237263
 - Augenzentrum Dr Hamacher /ID# 235537
 - Bugat Pal Korhaz /ID# 238144
 - Markusovszky Egyetemi Oktatokorhaz /ID# 237383
 - Budapest Retina Intezet /ID# 235950
 - Jahn Ferenc Del-pesti Korhaz es Rendelointezet /ID# 237111
 - Royal Victoria Eye and Ear Hospital /ID# 235546
 - Institute of Eye Surgery /ID# 235547
 - University of Catanzaro /ID# 238066
 - Eye Clinic University of Catania /ID# 235573
 - Ospedale Ss. Annunziata /ID# 236587
 - Fondazione IRCCS Policlinico /ID# 236909
 - University of Perugia /ID# 235811
 - Fondazione Bietti - Ospedale Britannico /ID# 235495
 - Sapienza University of Rome - Polo Pontino /ID# 237451
 - Southern Eye Specialists /ID# 236080
 - Capital Eye Specialists /ID# 236112
 - Wojskowy Instytut Medyczny /ID# 237031
 - Optimum Profesorskie Centrum Okulistyki Sp. z o.o. /ID# 237076
 - Gabinet Okulistyczny Edward Wylegala /ID# 235946
 - Medical Center Julianow /ID# 235961
 - Centrum Diagnostyki i Mikrochirurgii Oka - LENS sp. z o.o /ID# 235928
 - S. Fyodorov Eye Microsurgery Federal State Institution /ID# 235984
 - Pretoria Eye Institute - Private Practice /ID# 235658
 - Somerset Eye Specialist Medical & Surgical Centre /ID# 235540
 - Norrlands University hospital /ID# 237553
 - The Princess Alexandra NHS Trust /ID# 234433
 - Oxford University Hospitals NHS Foundation Trust /ID# 237282
 - Cambridge University Hospitals NHS Foundation Trust /ID# 238255
 - Mid Essex Hospitals NHS Trust /ID# 237776
 - East Suffolk and North Essex NHS Foundation Trust /ID# 234657
 - Mid-Cheshire Hospitals NHS Trust /ID# 235418
 - Liverpool University Hospitals NHS Foundation Trust /ID# 237095
 - Liverpool University Hospitals NHS Foundation Trust /ID# 237321
 - Central Middlesex Hospital /ID# 236216
 - King's College Hospital NHS Foundation Trust /ID# 237275
 - York and Scarborough Teaching Hospitals NHS Foundation Trust /ID# 237683
 
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Bimatoprost SR - Dose A
Bimatoprost SR - Dose B
Study Eye: Participants will receive 1 - 3 Cycles of Bimatoprost SR administrations of Dose A Fellow Eye: The eye that does not receive Bimatoprost SR treatment will receive standard of care or up to one administration of Bimatoprost SR.
Study Eye: Participants received 1-3 Cycles of Bimatoprost SR administrations of Dose B Fellow Eye: The eye that does not receive Bimatoprost SR treatment will receive standard of care or up to one administration of Bimatoprost SR.